Filing Flows › Comparisons › AURX vs XAIR
Nuo Therapeutics vs Beyond Air: AURX and XAIR compared
Nuo Therapeutics is the larger company: $1.8M of revenue in its latest quarter (Q2 2026) against $1.8M for Beyond Air (Q1 FY27). Nuo Therapeutics is growing faster (+153% against +0.5% a year earlier). Nuo Therapeutics is more profitable, with an operating margin of -9.4% against -374.0%.
Where the money goes: AURX and XAIR
Nuo Therapeutics (AURX) · Q2 2026
Nuo Therapeutics, Q2 2026: revenue $1.8M (+153% year over year), operating margin -9.4%, net loss $278K, operating cash flow −$236K. The chart follows the revenue to costs, profit and cash.
Beyond Air (XAIR) · Q1 FY27
Beyond Air, Q1 FY27: revenue $1.8M (+0.5% year over year), operating margin -374.0%, net loss $8.2M, operating cash flow −$4.9M. The chart follows the revenue to costs, profit and cash.
| Nuo Therapeutics (AURX) | Beyond Air (XAIR) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $1.8M | $1.8M |
| Revenue growth, Y/Y | +153% | +0.5% |
| Operating margin | -9.4% | -374.0% |
| Net earnings | −$278K | −$8.2M |
| Net margin | -15.7% | -461.2% |
| Operating cash flow | −$236K | −$4.9M |
Where the revenue comes from
Nuo Therapeutics
- Product: $1.7M (96%)
- Aurix and Private Label Centrifuge Devices: $72K (4%)
Questions
Which is bigger, Nuo Therapeutics or Beyond Air?
Nuo Therapeutics is the larger company: $1.8M of revenue in its latest quarter (Q2 2026) against $1.8M for Beyond Air (Q1 FY27).
Is Nuo Therapeutics or Beyond Air growing faster?
Nuo Therapeutics is growing faster (+153% against +0.5% a year earlier).
Which is more profitable, Nuo Therapeutics or Beyond Air?
Nuo Therapeutics is more profitable, with an operating margin of -9.4% against -374.0%.
More: Nuo Therapeutics earnings · how Nuo Therapeutics makes money · Beyond Air earnings · how Beyond Air makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.